Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer

Bridging the Lab and the Clinic in Cancer Medicine

Cancer Research	Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention	Molecular Cancer Therapeutics
Molecular Cancer Research	Cancer Prevention Research
Cancer Prevention Journals Portal	Cancer Reviews Online
Annual Meeting Education Book	Meeting Abstracts Online

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Latil, A.
	Articles by Lidereau, R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Latil, A.
	Articles by Lidereau, R.

ARTICLES

Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer

A Latil, O Cussenot, G Fournier, JC Baron and R Lidereau
Laboratoire d'Oncogenetique, Centre Rene Huguenin, 5 rue Gaston Latouche, F-92211 St-Cloud, France.

It is widely accepted that an accumulation of genetic alterations plays an important role in the genesis of human cancers, but little is known about prostate cancer in this respect. Recent studies have identified regions on chromosome arms 8p, 10q, 16q, and 18q that are frequently deleted in human prostate cancer. We have previously described a loss of heterozygosity (LOH) at the Met locus on chromosome band 7q31 in a study of 20 localized prostate tumors. To determine whether a region on the 7q arm is important in the initiation and/or progression of prostate cancer, prostate tissue from 13 patients with confined prostate tumors, 17 with local extracapsular extension, and 13 with metastatic forms were analyzed for LOH, using a DNA probe for RFLP (pMetH) and 8 CA microsatellite repeats (7 on 7q21-q33 and 1 on 7p). Twenty (47%) of the 43 cases studied showed LOH at one or more 7q loci. The most frequently deleted region was chromosome 7q31.1-7q31.2, whereas the centromeric locus on 7q21 was generally conserved. The percentage of LOH was normally distributed around the D7S480 locus. Moreover, the rate of LOH in the 7q31 region was lower in metastatic tumors than in localized tumors. These results strongly suggest the presence of a tumor suppressor gene on the chromosome band 7q31 with an important role in the early stages of prostate cancer.

This article has been cited by other articles:

A. Drusco, N. Zanesi, C. Roldo, F. Trapasso, J. L. Farber, L. Y. Fong, and C. M. Croce
Knockout mice reveal a tumor suppressor function for Testin
PNAS, August 2, 2005; 102(31): 10947 - 10951.
[Abstract] [Full Text] [PDF]

R. von Knobloch, L. Konrad, P. J. Barth, H. Brandt, S. Wille, A. Heidenreich, R. Moll, and R. Hofmann
Genetic Pathways and New Progression Markers for Prostate Cancer Suggested by Microsatellite Allelotyping
Clin. Cancer Res., February 1, 2004; 10(3): 1064 - 1073.
[Abstract] [Full Text] [PDF]

H. B. Urnovitz, J. C. Sturge, T. D. Gottfried, and W. H. Murphy
Urine Antibody Tests: New Insights into the Dynamics of HIV-1 Infection
Clin. Chem., September 1, 1999; 45(9): 1602 - 1613.
[Abstract] [Full Text] [PDF]

				R. von Knobloch, L. Konrad, P. J. Barth, H. Brandt, S. Wille, A. Heidenreich, R. Moll, and R. Hofmann Genetic Pathways and New Progression Markers for Prostate Cancer Suggested by Microsatellite Allelotyping Clin. Cancer Res., February 1, 2004; 10(3): 1064 - 1073. [Abstract] [Full Text] [PDF]

				H. B. Urnovitz, J. C. Sturge, T. D. Gottfried, and W. H. Murphy Urine Antibody Tests: New Insights into the Dynamics of HIV-1 Infection Clin. Chem., September 1, 1999; 45(9): 1602 - 1613. [Abstract] [Full Text] [PDF]